Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chloroprocaine + ropivacaine
- Development stage
- Unknown
- Lead developer
- Anhui Province Maternity and Child Health Hospital
- Modality
- Small Molecules
- Administration
- Epidural, Intrathecal
01
Overview
Chloroprocaine + ropivacaine is a local anesthetic combination therapy utilized for labor analgesia. Chloroprocaine is an ester-type anesthetic characterized by a very rapid onset and short duration of action due to rapid hydrolysis by plasma pseudocholinesterase. Ropivacaine is an amide-type anesthetic that provides long-lasting sensory blockade with minimal motor block and reduced cardiotoxicity compared to bupivacaine. By combining these two agents, clinicians aim to achieve a fast-acting loading dose effect from chloroprocaine followed by the sustained relief provided by ropivacaine. This combination is specifically studied by institutions like Hefei Maternal and Child Health Hospital to improve the management of labor pain.
- Other names
- chloroprocaine hydrochloride + ropivacaine hydrochloride
02
Targets
SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN10A (Sodium channel protein type X alpha subunit)SCN11A (NaV1.9)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)SCN3A (Sodium channel protein type 3 subunit alpha)SCN4A (Voltage-gated sodium channel protein type 4 subunit alpha)SCN5A (Sodium channel protein type 5 subunit alpha)SCN8A (NaV1.6)SCN9A (Sodium channel protein type 9 subunit alpha)
Beyond the preview
Go deeper on chloroprocaine + ropivacaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chloroprocaine + ropivacaine.